Microbial contamination and biofilm formation in food systems remain major challenges for global food safety and public health. Pathogenic bacteria such as ...

A QUT-led pilot study has shown the use of a relatively simple and cost-effective method of monitoring the presence of ...

Three Consecutive Years of Ongoing Predictable Media™ Partnership NEW YORK CITY, NY / ACCESS Newswire / April 7, 2026 / ...

Relatives of modern humans may have created and used a sticky substance both as a glue and to treat their wounds, preempting ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial ...

Even though having an itch is innocuous, the underlying reason you have the itch in the first place could be more disgusting ...

Systematic review details microbial and clinical response rates, safety of experimental tr ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage ...

Hospital wastewater is difficult to clean because it often carries two very different threats at once: chemical dye residues and harmful bacteria. Researchers have now developed a polyurethane ...

- Notable Investors of Combined Company Include American Venture Partners Eric Trumpand Donald Trump Jr.; Additional Support fromLeading U.S. Drone Manufacturer Unusual Machines (“UMAC”) and a ...

A study led by researchers from the Infectious Diseases Service of the Bellvitge University Hospital (HUB), the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB) ...